BACKGROUND: Cytomegalovirus (CMV) remains an important pathogen in solid organ transplantation, particularly lung transplantation. Lung transplant recipients (LTRs) mismatched for CMV (donor positive/recipient negative [D(+)R(-)]) are at highest risk for active CMV infection and have increased mortality. However, the correlates of immune control during chronic CMV infection remain incompletely understood. METHODS: We prospectively studied 22 D(+)R(-) LTRs during primary CMV infection and into chronic infection. Immune responses during primary infection were analyzed for association with viral relapse during early chronic infection. RESULTS: Primary CMV infection was characterized by a striking induction of T-box transcription factor (T-bet) in CD8(+) T cells. CMV-specific effector CD8(+) T cells were found to be T-bet(+). After primary infection, 7 LTRs lacked immune control with relapsing viremia during early chronic infection. LTRs with relapsing viremia had poor induction of T-bet and low frequencies of phosphoprotein 65 (pp65)-specific CD8(+) effector T cells during primary infection. However, frequencies of IE1-specific CD8(+) effector T cells during primary infection were not associated with early relapsing viremia. CONCLUSIONS: T-bet plays an important role in coordinating CD8(+) effector responses to CMV during primary infection. Moreover, CD8(+) T-bet induction and pp65-specific CD8(+) effector responses at the time of primary infection are important predictors of immune control of CMV during early chronic infection.
BACKGROUND: Cytomegalovirus (CMV) remains an important pathogen in solid organ transplantation, particularly lung transplantation. Lung transplant recipients (LTRs) mismatched for CMV (donor positive/recipient negative [D(+)R(-)]) are at highest risk for active CMV infection and have increased mortality. However, the correlates of immune control during chronic CMV infection remain incompletely understood. METHODS: We prospectively studied 22 D(+)R(-) LTRs during primary CMV infection and into chronic infection. Immune responses during primary infection were analyzed for association with viral relapse during early chronic infection. RESULTS:Primary CMV infection was characterized by a striking induction of T-box transcription factor (T-bet) in CD8(+) T cells. CMV-specific effector CD8(+) T cells were found to be T-bet(+). After primary infection, 7 LTRs lacked immune control with relapsing viremia during early chronic infection. LTRs with relapsing viremia had poor induction of T-bet and low frequencies of phosphoprotein 65 (pp65)-specific CD8(+) effector T cells during primary infection. However, frequencies of IE1-specific CD8(+) effector T cells during primary infection were not associated with early relapsing viremia. CONCLUSIONS:T-bet plays an important role in coordinating CD8(+) effector responses to CMV during primary infection. Moreover, CD8(+) T-bet induction and pp65-specific CD8(+) effector responses at the time of primary infection are important predictors of immune control of CMV during early chronic infection.
Authors: Supha K Arthurs; Albert J Eid; Rachel A Pedersen; Walter K Kremers; Fernando G Cosio; Robin Patel; Raymund R Razonable Journal: Clin Infect Dis Date: 2008-03-15 Impact factor: 9.079
Authors: Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech Journal: Immunity Date: 2007-08 Impact factor: 31.745
Authors: A Oxenius; H F Günthard; B Hirschel; S Fidler; J N Weber; P J Easterbrook; J I Bell; R E Phillips; D A Price Journal: Eur J Immunol Date: 2001-04 Impact factor: 5.532
Authors: Matthew R Pipeling; Erin E West; Christine M Osborne; Amanda B Whitlock; Lesia K Dropulic; Matthew H Willett; Michael Forman; Alexandra Valsamakis; Jonathan B Orens; David R Moller; Noah Lechtzin; Stephen A Migueles; Mark Connors; John F McDyer Journal: J Immunol Date: 2008-07-01 Impact factor: 5.422
Authors: Katrin D Mayer; Katja Mohrs; William Reiley; Susan Wittmer; Jacob E Kohlmeier; John E Pearl; Andrea M Cooper; Lawrence L Johnson; David L Woodland; Markus Mohrs Journal: J Immunol Date: 2008-01-15 Impact factor: 5.422
Authors: Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker Journal: J Exp Med Date: 2005-09-05 Impact factor: 14.307
Authors: Andrew M Intlekofer; Naofumi Takemoto; Charlly Kao; Arnob Banerjee; Felix Schambach; John K Northrop; Hao Shen; E John Wherry; Steven L Reiner Journal: J Exp Med Date: 2007-08-13 Impact factor: 14.307
Authors: Aki Hoji; Iulia D Popescu; Matthew R Pipeling; Pali D Shah; Spencer A Winters; John F McDyer Journal: J Immunol Date: 2019-09-25 Impact factor: 5.422
Authors: Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar Journal: J Infect Dis Date: 2020-03-05 Impact factor: 5.226
Authors: Iulia Popescu; Matthew R Pipeling; Hannah Mannem; Pali D Shah; Jonathan B Orens; Mark Connors; Stephen A Migueles; John F McDyer Journal: J Immunol Date: 2015-12-11 Impact factor: 5.422
Authors: Mohammad Raeiszadeh; Annette Pachnio; Jusnara Begum; Charles Craddock; Paul Moss; Frederick E Chen Journal: Haematologica Date: 2015-05-14 Impact factor: 9.941
Authors: Iulia Popescu; Hannah Mannem; Spencer A Winters; Aki Hoji; Fernanda Silveira; Emily McNally; Matthew R Pipeling; Elizabeth A Lendermon; Matthew R Morrell; Joseph M Pilewski; Vidya Sagar Hanumanthu; Yingze Zhang; Swati Gulati; Pali D Shah; Carlo J Iasella; Christopher R Ensor; Mary Armanios; John F McDyer Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 30.528